Esophageal candidiasis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Ahmed Younes (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}};{{AE}}{{AY}} | {{CMG}};{{AE}}{{AY}} | ||
==Overview== | ==Overview== | ||
Secondary prevention strategies following esophageal candidiasis in [[HIV]] patients include prophylactic [[fluconazole]] therapy. | |||
==Secondary prevention== | ==Secondary prevention== | ||
* | *Secondary prevention strategies following esophageal candidiasis in [[HIV]] patients include prophylactic [[fluconazole]] therapy in a dose of 100-200 mg repeated 3 times/week.<ref name="pmid26679628">{{cite journal |vauthors=Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD |title=Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America |journal=Clin. Infect. Dis. |volume=62 |issue=4 |pages=e1–50 |year=2016 |pmid=26679628 |pmc=4725385 |doi=10.1093/cid/civ933 |url=}}</ref> | ||
*It has been proven to decrease recurrence of esophageal candidiasis. | |||
==References== | |||
{{reflist|2}} | |||
[[Category:Emergency medicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Otolaryngology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 21:40, 29 July 2020
|
Esophageal candidiasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Esophageal candidiasis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Esophageal candidiasis secondary prevention |
|
Risk calculators and risk factors for Esophageal candidiasis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]
Overview
Secondary prevention strategies following esophageal candidiasis in HIV patients include prophylactic fluconazole therapy.
Secondary prevention
- Secondary prevention strategies following esophageal candidiasis in HIV patients include prophylactic fluconazole therapy in a dose of 100-200 mg repeated 3 times/week.[1]
- It has been proven to decrease recurrence of esophageal candidiasis.
References
- ↑ Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD (2016). "Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America". Clin. Infect. Dis. 62 (4): e1–50. doi:10.1093/cid/civ933. PMC 4725385. PMID 26679628.